Influence of the selective serotonin re‐uptake inhibitor, paroxetine, on gastric sensorimotor function in humans
Summary Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine. Aim : To study th...
Saved in:
Published in | Alimentary pharmacology & therapeutics Vol. 17; no. 4; pp. 603 - 608 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
15.02.2003
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0269-2813 1365-2036 |
DOI | 10.1046/j.1365-2036.2003.01469.x |
Cover
Abstract | Summary
Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine.
Aim : To study the influence of a selective 5‐hydroxytryptamine re‐uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal.
Methods : Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre‐treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured.
Results : Pre‐treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 ± 2.3 vs. 4.0 ± 2.0 mmHg and 13.3 ± 3.1 vs. 12.7 ± 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 ± 90 vs. 417 ± 114 mL and 772 ± 74 vs. 750 ± 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal‐induced fundus relaxation (136 ± 51 vs. 255 ± 43 mL, P < 0.05).
Conclusions : Pre‐treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5‐hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post‐prandial fundus relaxation. |
---|---|
AbstractList | Background
: The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine.
Aim
: To study the influence of a selective 5‐hydroxytryptamine re‐uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal.
Methods
: Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre‐treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured.
Results
: Pre‐treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 ± 2.3 vs. 4.0 ± 2.0 mmHg and 13.3 ± 3.1 vs. 12.7 ± 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 ± 90 vs. 417 ± 114 mL and 772 ± 74 vs. 750 ± 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal‐induced fundus relaxation (136 ± 51 vs. 255 ± 43 mL,
P
< 0.05).
Conclusions
: Pre‐treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5‐hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post‐prandial fundus relaxation. Summary Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5‐hydroxytryptamine. Aim : To study the influence of a selective 5‐hydroxytryptamine re‐uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal. Methods : Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre‐treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured. Results : Pre‐treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 ± 2.3 vs. 4.0 ± 2.0 mmHg and 13.3 ± 3.1 vs. 12.7 ± 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 ± 90 vs. 417 ± 114 mL and 772 ± 74 vs. 750 ± 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal‐induced fundus relaxation (136 ± 51 vs. 255 ± 43 mL, P < 0.05). Conclusions : Pre‐treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5‐hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post‐prandial fundus relaxation. The role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5-hydroxytryptamine.BACKGROUNDThe role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5-hydroxytryptamine.To study the influence of a selective 5-hydroxytryptamine re-uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal.AIMTo study the influence of a selective 5-hydroxytryptamine re-uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal.Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre-treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured.METHODSSixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre-treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured.Pre-treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 +/- 2.3 vs. 4.0 +/- 2.0 mmHg and 13.3 +/- 3.1 vs. 12.7 +/- 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 +/- 90 vs. 417 +/- 114 mL and 772 +/- 74 vs. 750 +/- 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal-induced fundus relaxation (136 +/- 51 vs. 255 +/- 43 mL, P < 0.05).RESULTSPre-treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 +/- 2.3 vs. 4.0 +/- 2.0 mmHg and 13.3 +/- 3.1 vs. 12.7 +/- 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 +/- 90 vs. 417 +/- 114 mL and 772 +/- 74 vs. 750 +/- 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal-induced fundus relaxation (136 +/- 51 vs. 255 +/- 43 mL, P < 0.05).Pre-treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5-hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post-prandial fundus relaxation.CONCLUSIONSPre-treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5-hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post-prandial fundus relaxation. The role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both centrally and peripherally to enhance the availability of physiologically released 5-hydroxytryptamine. To study the influence of a selective 5-hydroxytryptamine re-uptake inhibitor, paroxetine, on gastric fundus tone, on the perception to gastric distension and on gastric accommodation to a meal. Sixteen healthy volunteers underwent a gastric barostat study on two occasions, after pre-treatment with placebo or paroxetine, 20 mg/day. Graded isobaric and isovolumetric distensions were performed and perception was scored by a questionnaire. Subsequently, the amplitude of the gastric accommodation to a mixed liquid meal was also measured. Pre-treatment with paroxetine did not alter the thresholds for perception and discomfort during isobaric (4.7 +/- 2.3 vs. 4.0 +/- 2.0 mmHg and 13.3 +/- 3.1 vs. 12.7 +/- 2.3 mmHg above the minimum intragastric distending pressure, N.S.) and isovolumetric (307 +/- 90 vs. 417 +/- 114 mL and 772 +/- 74 vs. 750 +/- 76 mL, N.S.) distensions. Paroxetine significantly enhanced the amplitude of the meal-induced fundus relaxation (136 +/- 51 vs. 255 +/- 43 mL, P < 0.05). Pre-treatment with paroxetine enhances gastric accommodation to a meal. These data suggest that the release of 5-hydroxytryptamine, probably at the level of the enteric nervous system, is involved in the control of the accommodation reflex in humans, and that paroxetine may be beneficial to patients with impaired post-prandial fundus relaxation. |
Author | Coulie, B. Fischler, B. Tack, J. Janssens, J. Broekaert, D. |
Author_xml | – sequence: 1 givenname: J. surname: Tack fullname: Tack, J. – sequence: 2 givenname: D. surname: Broekaert fullname: Broekaert, D. – sequence: 3 givenname: B. surname: Coulie fullname: Coulie, B. – sequence: 4 givenname: B. surname: Fischler fullname: Fischler, B. – sequence: 5 givenname: J. surname: Janssens fullname: Janssens, J. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14643943$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12622770$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1uFDEQhS0URCaBKyBvYJVu3LbH7l6AFEX8RIoEi7C2bKfMeOixB9sdJjuOwBk5CW5mCBIbWFVJ9b1XLr8TdBRiAIRwR9qOcPFi3XZMLBtKmGgpIawlHRdDu3uAFveDI7QgVAwN7Tt2jE5yXhNChCT0ETruqKBUSrJA6TK4cYJgAUeHywpwhhFs8bdzl2KJwQec4Me379O26M-AfVh540tMZ3irU9xB8QHOcAz4k84leVt1IcfkN1WcsJtCdavTarOaNjrkx-ih02OGJ4d6ij6-eX198a65ev_28uL8qrF8IEPTkYEbcwNCUAnLngmmeyMN0xq0MyCX0gCtdxgriXWDq-CSaGNBACVaSHaKnu99tyl-mSAXtfHZwjjqAHHKSjLS857zCj49gJPZwI3a1rfrdKd-_1IFnh0Ana0eXdLB-vyH44KzgbPKvdpzNsWcEzhlfdHz9SVpP6qOqDk-tVZzSmpOSc3xqV_xqV016P8yuN_xb-nLvfSrH-Huv3Xq_MP13LGf9ni05Q |
CitedBy_id | crossref_primary_10_1111_j_1365_2982_2007_00966_x crossref_primary_10_1016_S0399_8320_06_73195_5 crossref_primary_10_1371_journal_pone_0157798 crossref_primary_10_1053_j_gastro_2017_11_279 crossref_primary_10_1038_ajg_2011_179 crossref_primary_10_1152_ajpgi_00044_2011 crossref_primary_10_1111_nmo_13146 crossref_primary_10_1177_1756283X11409279 crossref_primary_10_1038_nrgastro_2013_11 crossref_primary_10_1097_00132980_200502000_00016 crossref_primary_10_1517_14728214_2011_558502 crossref_primary_10_3390_gidisord6010016 crossref_primary_10_3748_wjg_15_6052 crossref_primary_10_1016_S2468_1253_18_30003_7 crossref_primary_10_1111_j_1365_2982_2006_00863_x crossref_primary_10_3748_wjg_15_25 crossref_primary_10_1016_j_dld_2005_04_001 crossref_primary_10_1097_MD_0000000000017501 crossref_primary_10_1111_nmo_12210 crossref_primary_10_1177_26345161231160723 crossref_primary_10_1517_14656566_2010_501794 crossref_primary_10_1007_s11938_004_0012_6 crossref_primary_10_1111_j_1365_2036_2010_04522_x crossref_primary_10_1111_j_1365_2982_2010_01613_x crossref_primary_10_1111_j_1365_2982_2010_01655_x crossref_primary_10_3389_fpsyt_2020_00172 crossref_primary_10_1016_j_gtc_2010_08_005 crossref_primary_10_1111_j_1365_2036_2006_02772_x crossref_primary_10_1046_j_1365_2036_2003_01775_x crossref_primary_10_1111_j_1365_2036_2009_04121_x crossref_primary_10_1152_ajpgi_00020_2010 crossref_primary_10_6064_2012_424802 crossref_primary_10_1155_2015_168252 crossref_primary_10_1007_s00535_006_1966_z crossref_primary_10_1111_j_1365_2036_2008_03677_x crossref_primary_10_1517_14656566_2013_809063 crossref_primary_10_1053_j_gastro_2006_11_002 crossref_primary_10_1111_j_1365_2982_2006_00891_x crossref_primary_10_1152_ajpgi_90525_2008 crossref_primary_10_1016_j_gastrohep_2012_05_002 crossref_primary_10_1111_j_1365_2036_2006_03005_x crossref_primary_10_1111_j_1365_2982_2011_01671_x crossref_primary_10_1177_1756283X10362639 crossref_primary_10_1097_00001574_200411000_00007 crossref_primary_10_1111_j_1365_2982_2006_00876_x crossref_primary_10_1038_oby_2006_154 crossref_primary_10_1111_j_1365_2036_2005_02472_x crossref_primary_10_1016_j_dld_2003_09_012 crossref_primary_10_1007_s11938_007_0069_0 crossref_primary_10_1111_jgh_13168 crossref_primary_10_1152_ajpgi_00252_2009 crossref_primary_10_1016_j_gtc_2014_11_003 crossref_primary_10_1016_j_aprim_2012_05_003 crossref_primary_10_1136_gutjnl_2015_310721 crossref_primary_10_1152_ajpgi_00046_2009 crossref_primary_10_1007_s40265_020_01362_4 crossref_primary_10_1111_j_1365_2036_2006_02951_x crossref_primary_10_1111_j_1365_2036_2006_02930_x crossref_primary_10_1053_j_gastro_2015_04_020 crossref_primary_10_1080_14656566_2019_1707805 crossref_primary_10_1007_s11894_008_0070_3 crossref_primary_10_1016_j_bpg_2004_04_003 crossref_primary_10_1371_journal_pone_0138927 crossref_primary_10_4062_biomolther_2012_096 crossref_primary_10_1111_j_1365_2982_2007_01068_x crossref_primary_10_1007_s11894_005_0021_1 crossref_primary_10_1053_j_gastro_2004_05_030 crossref_primary_10_1097_01_mcg_0000156109_97999_d1 crossref_primary_10_1111_nmo_13491 crossref_primary_10_1002_14651858_CD008321 crossref_primary_10_3748_wjg_v12_i17_2694 crossref_primary_10_3748_wjg_v12_i9_1329 crossref_primary_10_1038_ajg_2017_52 crossref_primary_10_1111_j_1365_2982_2004_00613_x crossref_primary_10_5812_jamm_30057 crossref_primary_10_1159_000357854 crossref_primary_10_1016_j_coph_2007_09_012 crossref_primary_10_2478_sjecr_2020_0031 crossref_primary_10_1007_s11938_005_0026_8 crossref_primary_10_1016_S1542_3565_05_00531_8 crossref_primary_10_1111_j_1365_2036_2005_02392_x crossref_primary_10_1111_j_1365_2036_2005_02471_x crossref_primary_10_1586_17474124_2_3_411 crossref_primary_10_1517_14740338_5_2_313 crossref_primary_10_1371_journal_pone_0169113 crossref_primary_10_1007_s11938_007_0068_1 crossref_primary_10_1016_j_amjms_2020_04_018 |
Cites_doi | 10.1136/gut.51.2.212 10.1053/gast.2002.33663 10.1113/jphysiol.1967.sp008334 10.1046/j.1365-2036.1998.00366.x 10.1097/00004714-199812000-00005 10.1016/0165-1838(93)90330-W 10.1016/0016-5085(95)90057-8 10.1136/gut.51.2.219 10.1136/gut.42.6.823 10.1016/S0016-5085(98)70012-5 10.1046/j.1365-2982.2002.00344.x 10.1136/gut.35.3.327 10.1007/BF02213124 10.1136/gut.35.4.496 10.1113/jphysiol.1981.sp013599 10.1038/351477a0 10.1111/j.1476-5381.1979.tb16089.x 10.1136/gut.46.4.468 |
ContentType | Journal Article |
Copyright | 2003 INIST-CNRS |
Copyright_xml | – notice: 2003 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1046/j.1365-2036.2003.01469.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2036 |
EndPage | 608 |
ExternalDocumentID | 12622770 14643943 10_1046_j_1365_2036_2003_01469_x APT1469 |
Genre | article Clinical Trial Randomized Controlled Trial Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DTERQ E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GODZA GX1 H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TR2 TUS UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YOC ZZTAW ~IA ~WT AAYXX AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c4909-1094bbde6627e58363a8b7b3aaeafbe757be2262bc70cf9fe6650abce6e20a673 |
IEDL.DBID | DR2 |
ISSN | 0269-2813 |
IngestDate | Fri Jul 11 02:46:02 EDT 2025 Wed Feb 19 02:34:47 EST 2025 Mon Jul 21 09:14:01 EDT 2025 Thu Apr 24 22:58:23 EDT 2025 Tue Jul 01 00:27:24 EDT 2025 Wed Jan 22 16:26:52 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Stomach Paroxetine Healthy subject Serotonin Digestive system Postprandial Smooth muscle Reuptake inhibitor Sensitivity Piperidine derivatives Gastric fundus Muscular tonus |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4909-1094bbde6627e58363a8b7b3aaeafbe757be2262bc70cf9fe6650abce6e20a673 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
PMID | 12622770 |
PQID | 73084844 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_73084844 pubmed_primary_12622770 pascalfrancis_primary_14643943 crossref_citationtrail_10_1046_j_1365_2036_2003_01469_x crossref_primary_10_1046_j_1365_2036_2003_01469_x wiley_primary_10_1046_j_1365_2036_2003_01469_x_APT1469 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-02-15 |
PublicationDateYYYYMMDD | 2003-02-15 |
PublicationDate_xml | – month: 02 year: 2003 text: 2003-02-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | Alimentary pharmacology & therapeutics |
PublicationTitleAlternate | Aliment Pharmacol Ther |
PublicationYear | 2003 |
Publisher | Blackwell Science Ltd Blackwell |
Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell |
References | 1987; 252 1998; 18 2002; 14 1981; 311 1991; 35 1967; 192 2002; 51 2000; 46 1993; 43 1997; 110 1986; 251 2002; 122 1995; 108 1996; 41 1994; 35 1998; 115 1979; 66 1998; 42 1998; 12 1993; 384 e_1_2_13_12_2 e_1_2_13_13_2 e_1_2_13_23_2 e_1_2_13_15_2 e_1_2_13_20_2 e_1_2_13_10_2 e_1_2_13_11_2 e_1_2_13_21_2 e_1_2_13_8_2 e_1_2_13_7_2 Azpiroz F (e_1_2_13_4_2) 1986; 251 e_1_2_13_6_2 De Ponti F (e_1_2_13_3_2) 1987; 252 e_1_2_13_5_2 Meulemans AL (e_1_2_13_14_2) 1993; 384 e_1_2_13_9_2 e_1_2_13_2_2 e_1_2_13_16_2 e_1_2_13_17_2 e_1_2_13_18_2 e_1_2_13_19_2 Coulie B (e_1_2_13_22_2) 1997; 110 |
References_xml | – volume: 46 start-page: 468 year: 2000 end-page: 73 article-title: Effect of sumatriptan on gastric fundus tone and on the perception of gastric distension in man publication-title: Gut – volume: 35 start-page: 496 year: 1994 end-page: 500 article-title: 5‐Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5‐hydroxytryptamine reuptake publication-title: Gut – volume: 43 start-page: 241 year: 1993 end-page: 6 article-title: Role of nitric oxide and vasoactive intestinal polypeptide in vagally mediated relaxation of the gastric corpus in the anaesthetized ferret publication-title: J Autonomic Nervous System – volume: 42 start-page: 823 year: 1998 end-page: 9 article-title: Responses to gastric distension in functional dyspepsia publication-title: Gut – volume: 51 start-page: 212 year: 2002 end-page: 8 article-title: Role of nitric oxide in gastric motor and sensory functions in healthy subjects publication-title: Gut – volume: 192 start-page: 823 year: 1967 end-page: 46 article-title: 5‐Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach publication-title: J Physiol – volume: 110 start-page: A767 year: 1997 article-title: Influence of buspirone‐induced fundus relaxation on the perception of gastric distension in man publication-title: Gastroenterology – volume: 12 start-page: 761 year: 1998 end-page: 6 article-title: Influence of cisapride on gastric tone and on the perception of gastric distension publication-title: Aliment Pharmacol Ther – volume: 252 start-page: G595 year: 1987 end-page: 601 article-title: Reflex gastric relaxation in response to distension of the duodenum publication-title: Am J Physiol – volume: 122 start-page: 1738 year: 2002 end-page: 47 article-title: Clinical and pathophysiological characteristics of acute‐onset functional dyspepsia publication-title: Gastroenterology – volume: 18 start-page: 447 issue: 6 year: 1998 end-page: 54 article-title: Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review publication-title: J Clin Psychopharmacol – volume: 41 start-page: 689 year: 1996 end-page: 96 article-title: Impaired accommodation of proximal stomach to a meal in functional dyspepsia publication-title: Dig Dis Sci – volume: 384 start-page: 424 year: 1993 end-page: 30 article-title: The role of nitric oxide (NO) in 5‐HT induced relaxations of the guinea‐pig stomach publication-title: Naunyn-Schmiedeberg's Arch Pharmacol – volume: 66 start-page: 7 year: 1979 end-page: 9 article-title: Uptake and release of 5‐hydroxytryptamine by enteric 5‐hydroxytryptaminergic neurones: effects of fluoxetine and chlorimipramine publication-title: Br J Pharmacol – volume: 35 start-page: 477 year: 1991 end-page: 9 article-title: Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid publication-title: Nature – volume: 35 start-page: 327 year: 1994 end-page: 32 article-title: Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients publication-title: Gut – volume: 14 start-page: 395 year: 2002 end-page: 402 article-title: Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans publication-title: Neurogastroenterol Motil – volume: 51 start-page: 219 year: 2002 end-page: 24 article-title: Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans publication-title: Gut – volume: 115 start-page: 1346 year: 1998 end-page: 52 article-title: Role of impaired gastric accommodation to a meal in functional dyspepsia publication-title: Gastroenterology – volume: 311 start-page: 475 year: 1981 end-page: 88 article-title: The electrical basis for contraction and relaxation in canine fundal smooth muscle publication-title: J Physiol – volume: 251 start-page: G727 year: 1986 end-page: 35 article-title: Vagally mediated gastric relaxation induced by intestinal nutrients in the dog publication-title: Am J Physiol – volume: 108 start-page: 330 year: 1995 end-page: 6 article-title: Gastric tone determines the sensitivity of the stomach to distension publication-title: Gastroenterology – ident: e_1_2_13_8_2 doi: 10.1136/gut.51.2.212 – volume: 384 start-page: 424 year: 1993 ident: e_1_2_13_14_2 article-title: The role of nitric oxide (NO) in 5‐HT induced relaxations of the guinea‐pig stomach publication-title: Naunyn-Schmiedeberg's Arch Pharmacol – ident: e_1_2_13_16_2 doi: 10.1053/gast.2002.33663 – ident: e_1_2_13_13_2 doi: 10.1113/jphysiol.1967.sp008334 – ident: e_1_2_13_21_2 doi: 10.1046/j.1365-2036.1998.00366.x – ident: e_1_2_13_18_2 doi: 10.1097/00004714-199812000-00005 – volume: 251 start-page: G727 year: 1986 ident: e_1_2_13_4_2 article-title: Vagally mediated gastric relaxation induced by intestinal nutrients in the dog publication-title: Am J Physiol – volume: 252 start-page: G595 year: 1987 ident: e_1_2_13_3_2 article-title: Reflex gastric relaxation in response to distension of the duodenum publication-title: Am J Physiol – ident: e_1_2_13_6_2 doi: 10.1016/0165-1838(93)90330-W – ident: e_1_2_13_20_2 doi: 10.1016/0016-5085(95)90057-8 – ident: e_1_2_13_7_2 doi: 10.1136/gut.51.2.219 – volume: 110 start-page: A767 year: 1997 ident: e_1_2_13_22_2 article-title: Influence of buspirone‐induced fundus relaxation on the perception of gastric distension in man publication-title: Gastroenterology – ident: e_1_2_13_12_2 doi: 10.1136/gut.42.6.823 – ident: e_1_2_13_11_2 doi: 10.1016/S0016-5085(98)70012-5 – ident: e_1_2_13_23_2 doi: 10.1046/j.1365-2982.2002.00344.x – ident: e_1_2_13_9_2 doi: 10.1136/gut.35.3.327 – ident: e_1_2_13_10_2 doi: 10.1007/BF02213124 – ident: e_1_2_13_19_2 doi: 10.1136/gut.35.4.496 – ident: e_1_2_13_2_2 doi: 10.1113/jphysiol.1981.sp013599 – ident: e_1_2_13_5_2 doi: 10.1038/351477a0 – ident: e_1_2_13_17_2 doi: 10.1111/j.1476-5381.1979.tb16089.x – ident: e_1_2_13_15_2 doi: 10.1136/gut.46.4.468 |
SSID | ssj0006702 |
Score | 2.0554464 |
Snippet | Summary
Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake... Background : The role of 5‐hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5‐hydroxytryptamine re‐uptake... The role of 5-hydroxytryptamine in the control of gastric fundus tone in humans is still unknown. Selective 5-hydroxytryptamine re-uptake inhibitors act both... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 603 |
SubjectTerms | Adult Biological and medical sciences Compliance Digestive system Female Gastric Fundus - drug effects Gastric Fundus - physiology Humans Male Medical sciences Paroxetine - pharmacology Perception Pharmacology. Drug treatments Pressure Serotonin Uptake Inhibitors - pharmacology |
Title | Influence of the selective serotonin re‐uptake inhibitor, paroxetine, on gastric sensorimotor function in humans |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2036.2003.01469.x https://www.ncbi.nlm.nih.gov/pubmed/12622770 https://www.proquest.com/docview/73084844 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEB1KDqFQ-v3hNk116DFenLUsyceQNKSFlFISyM1I8rgNW-zF9kLJKT-hv7G_pDOynWVLDqH0ZliPsWZnRk_W6D2A99oa67BUsba0XJVJSSnlJMaJVU7lVelVkAM6_axOzuWni-xi7H_iszADP8TNBzfOjFCvOcGtG1RIksBuO3VoUQkOtJ4zpkHJZ4wn6Qem0T_6umaSUjq0H9KKI4_nZj8dm3rGDc5bH7QxUz1Y2o6cVg1qF7fB0U10G6an40ewmAY2dKUsZqvezfzVX5yP_2fkj-HhiGLFwRB2T-Ae1k9h-3Tcp38G7cdJ-0Q0lSCMKbqgt0Olla7apuePwKLF39e_VsveLlBc1t8vHVWXdk8sLQ2CT2Ljnmhq8c2ytIgnu7prWg6tphU8HXNIkZ0IMoPdczg__nB2eBKP6g6xlzlrMNDC0rkSmYEeM5Oq1BqnXWot2sqhzrRDwoZz53Xiq7yiG7PEOo8K5xRJOn0BW3VT4ysQhFO8oWDMK_KQN97Q80ziS6NkRUs2jEBP_2ThR-pzVuD4UYQteMnH1dilBbuUhTnTIri0-BnB_o3lcqD_uIPN7kawrA0lwz-ZRvBuip6Ckpl3aGyNzaorqNwaaaSM4OUQVGtb8sRc6yQCFULjzm9THHw546vX_2r4Bu6HBkYWwcl2YKtvV_iWgFjvdkOK_QGpaSZ1 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hVgIk1PJPKLQ-cGyWdOPYzrECqi10K4S2Um-W7ThQtUpWSVZCnHgEnpEnYcbJdrWohwpxy2EnWk9mxt94xvMBvJFGGesLEUuD6SpPCnQpy32cGGFFXhZOBDqg6amYnPGP59n5QAdEd2H6-RDXB27kGSFek4PTgfTboSzZe3lo0cIYHOZ6jmgOSj5CQLnJEXdQJvb-y2qWlJChARFzjjweq4N0aOsZSpw3vmltr3owNy2qrez5Lm4CpOv4NmxQR9twtVxa35dyOVp0duR-_DX18T-t_SFsDUCWHfaW9wju-Oox3J0Opfon0Bwv6U9YXTKEmawNlDsYXfGpqTs6B2aN__3z12LemUvPLqpvFxYDTLPP5gZXQZex_T6rK_bVELuIQ7mqrRuyrrphtCOTVaEcC0yD7VM4O_owezeJB4KH2PGcaBgwt7S28DSE3mcqFalRVtrUGG9K62UmrUd4OLZOJq7MS_xhlhjrvPBjNCaZPoONqq78C2AIVZxCe8xL1JBTTuH7VOIKJXiJWZuPQC4_pXbD9HMi4bjSoQrP6cYaqVSTSombM9VBpfp7BAfXkvN-AsgtZHbXrGUlyAkB8jSCvaX5aPRnKtKYyteLVmPEVVxxHsHz3qpWsqiJsZRJBCLYxq3_jT78PKOnl_8quAf3JrPpiT45Pv20A_dDPyNx4mSvYKNrFv414rLO7gZ_-wMVWSqU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hIlVIqPxD-Gl94Ngs6caxnWMFrFqgVYVaqbfIduxSLUqiJCtVnHgEnpEnYcbJdrWohwpx8yFjxZOZ8efMeD6At1IrbVwpYqnxuMqTEl3KcBcnWhiR-9KKQAd0dCwOzvin8-x8rH-iuzBDf4jrH27kGSFek4M3pX83ZiUHJw8VWhiCQ1vPCbVBySeIJ-9ygcCCANLXVSspIUP9IR458niq9tKxqmfMcN4409pWdb_RHWrND3QXN-HRdXgb9qfZA5gvVzaUpcwni95M7I-_mj7-n6U_hK0RxrL9we4ewR1XPYbNozFR_wTawyX5Cas9Q5DJukC4g7EVR23d019g1rrfP38tml7PHbusvl0aDC_tLms0LoKuYrtdVlfsQhO3iEW5qqtbsq26ZbQfk02hHAs8g91TOJt9PH1_EI_0DrHlOZEw4MnSmNJRC3qXqVSkWhlpUq2d9sbJTBqH4HBqrEyszz0-mCXaWCfcFE1Jps9go6or9wIYAhWr0BpzjxqyyiqcTyW2VIJ7PLO5COTySxZ27H1OFBzfi5CD53RfjVRakEqJmTMtgkqLqwj2riWbof_HLWS214xlJcgJ__E0gp2l9RTozZSi0ZWrF12B8VZxxXkEzwejWsmiJqZSJhGIYBq3fpti_-SURi__VXAHNk8-zIovh8efX8G9UMxIhDjZa9jo24V7g6CsN9vB2_4AaTEpQw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+the+selective+serotonin+re%E2%80%90uptake+inhibitor%2C+paroxetine%2C+on+gastric+sensorimotor+function+in+humans&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Tack%2C+J.&rft.au=Broekaert%2C+D.&rft.au=Coulie%2C+B.&rft.au=Fischler%2C+B.&rft.date=2003-02-15&rft.pub=Blackwell+Science+Ltd&rft.issn=0269-2813&rft.eissn=1365-2036&rft.volume=17&rft.issue=4&rft.spage=603&rft.epage=608&rft_id=info:doi/10.1046%2Fj.1365-2036.2003.01469.x&rft.externalDBID=10.1046%252Fj.1365-2036.2003.01469.x&rft.externalDocID=APT1469 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon |